In this role, the selected candidate will conduct and interpret a diverse array of molecular biology, biochemical and cell-based studies to produce, screen, and evaluate tool and therapeutic antibodies and proteins, including the quantification and optimization of their binding affinities, specificities, activities, and therapeutic drug levels in preclinical development.
In this role, you will leads development and execution of new and/or highly complex algorithms and statistical predictive models and determines analytical approaches and modeling techniques to evaluate potential future outcomes.
In this role, the selected candidate will participate as a member of a team in developing novel scientific capabilities of the company in adapting next generation sequencing technologies to novel therapeutic technologies.
In this role, the selected candidate will utilize statistical and machine learning techniques to aide in the interpretation of quantitative genomic data; develop analysis pipelines to process next generation sequencing and other quantitative genomic data.
The selected candidate will serve as an integral developer of new experimental genomic workflows. He or she will work as part of cross-functional teams composed of engineers and experimental and computational biologists.
The candidate will be an essential member of the CTI-Boston Biology Group. He or she will be able to work independently and creatively to design and execute key experiments to address the basic and translational biology of novel drug targets, their molecular pathways, and their connection to human disease. The candidate will be expected to support projects in one or more therapeutic areas of interest to Pfizer including Immunology, Oncology, Immuno-Oncology, Neurodegenerative Disease, and others.
The Research Scientist III is expected to demonstrate expertise in both the theoretical and practical aspects of Analytical Chemistry. A major component in the scientists performance rating will be based on productivity.
In this role, you will work will directly impact our customers in the form of products and services that make use of speech and language technology. You will leverage Amazons heterogeneous data sources and large-scale computing resources to accelerate advances in spoken language understanding.
This position will be part of Pharmaceutical Research and Development within BioTherapeutics Pharmaceutical Sciences. The Scientist will participate in the development of parenteral formulations for biologics modalities such as monoclonal antibodies, antibody drug conjugates, proteins, vaccines, cell-based therapies and viral vectors for genomic therapeutics.
The individual will play a key role in developing the next generation immunogenicity risk assessment tools for lead biologics across diverse therapeutic areas and modalities utilizing cell-based in vitro assays.
The MIT Joint Program is developing advanced modeling frameworks to study economic and environmental implications of climate policies and their impacts on different sectors, including agriculture, energy, and transportation.
In this role, the selected candidate will perform metabolite extractions on biological samples including cells and tissue samples; maintain and troubleshoot U-HPLC, full-scan and QQQ mass spectrometers.